Other languages Johnson & Johnson Buenos Aires S.E.

Equities

JNJ

ARDEUT110236

End-of-day quote Buenos Aires S.E. Other stock markets 23:00:00 28/05/2024 BST			5-day change	1st Jan Change
11,691 ^ARS	-1.82%		-3.19%	+15.36%

05-29	Transcript : Johnson & Johnson Presents at Bernstein?s 40th Annual Strategic Decisions Conference, May-29-2024 01:30 PM
05-29	J&J: encouraging results in the treatment of depression	CF

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

J&J : résultats encourageants dans le soin de la dépression	05-29
Johnson & Johnson's Phase 3 Trial of Seltorexant to Treat Major Depressive Disorder Meets Primary, Secondary Endpoints	05-29
J&J's treatment for depression succeeds in late stage study	05-29
Sector Update: Health Care Stocks Fall Late Afternoon	05-28
Sector Update: Health Care Stocks Retreat Tuesday Afternoon	05-28
Sector Update: Health Care	05-28
Bio-Thera, Stada Enter Deal for Biosimilar Candidate to Johnson & Johnson's Simponi in EU, UK	05-28
Johnson & Johnson Agrees to Buy Numab Unit, Investigational Skin Disease Treatment For $1.25 Billion	05-28
Top Midday Stories: Wall Street Returns to T+1 Settlements; T-Mobile Buys US Cellular's Wireless Ops; Energy Transfer Buys WTG Midstream; GameStop Extends Rally	05-28
Johnson & Johnson to Acquire Experimental Eczema Drug for $1.25 Billion	05-28
Johnson & Johnson to Acquire Experimental Eczema Drug for $1.25 Billion	05-28
J&J : rachat d'une biotech suisse dans l'eczéma	05-28
J&J acquires rights to skin disorder drug for $1.25 bln	05-28
J&J : va présenter ses avancées lors de l'ASCO et de l'EHA	05-24
Víctimas de cáncer demandan a Johnson & Johnson por quiebras "fraudulentas"	05-22
Cancer victims sue Johnson & Johnson over 'fraudulent' bankruptcies	05-22
Johnson & Johnson Allegedly Engaged in 'Bad Faith' Bankruptcies That Harm Talc Victims, Lawsuit Says	05-22
Top Midday Stories: US Targets August 1 Start Date for China Tariff Hikes; CFPB Says BNPL Requires Credit Card-Level Oversight; Target Shares Fall on Earnings Miss; Third BHP Bid Rejected by Anglo American	05-22
Johnson & Johnson Allegedly Engaged in 'Bad Faith' Bankruptcies That Harm Talc Victims, Lawsuit Says	05-22
Nanobiotix to Transfer Phase 3 Head and Neck Cancer Study Sponsorship	05-21

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 05:30 pm